Singapore, Singapore

Kenneth Goh

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National University of Singapore. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth Goh. Retrieved from https://idiyas.com/inventor/kenneth-goh-296khs7o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenneth Goh: Innovator in Vaccine Development

Introduction

Kenneth Goh is a prominent inventor based in Singapore, known for his significant contributions to the field of vaccine development. His innovative approach has led to advancements in the generation of live attenuated vaccines, which are crucial for effective immunization.

Latest Patents

Kenneth Goh holds a patent for a "Rapid method of generating live attenuated vaccines." This invention relates to a method of generating a live attenuated vaccine and also encompasses the live attenuated vaccine produced according to this method. His work in this area is vital for enhancing vaccine efficacy and accessibility.

Career Highlights

Kenneth Goh is affiliated with the National University of Singapore, where he engages in research and development in the field of immunology. His academic and professional endeavors have positioned him as a key figure in vaccine innovation.

Collaborations

Throughout his career, Kenneth has collaborated with notable colleagues, including Eng Eong Ooi and Swee Sen Kwek. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in vaccine technology.

Conclusion

Kenneth Goh's contributions to vaccine development through his innovative methods and collaborations highlight his importance in the field. His work continues to impact public health positively, paving the way for future advancements in immunization.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…